CTVA vs LMNR
Corteva, Inc. and Limoneira Co., side by side — 8 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | CTVA | LMNR |
|---|---|---|
| Revenue | $17.4B | $153.7M |
| Net income | $1.1B | $-16.0M |
| Gross margin | 47.3% | −0.7% |
| Net margin | 6.4% | −10.6% |
| Return on equity | 4.6% | — |
| Diluted EPS | $1.60 | −$0.93 |
| Dividend / share | $0.70 | $0.30 |
| Payout ratio | 43.4% | −33.9% |
| Free cash flow | $2.8B | — |
| Equity | $24.1B | — |
| Net debt / equity | −0.09× | — |
| Current ratio | 1.43× | 1.35× |
| Revenue CAGR 5y | 4.1% | −0.8% |
| Profit CAGR 5y | 9.9% | — |
CTVA bills 113.2× the revenue of LMNR, and LMNR closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Revenue by year
8 years side by side
| Fiscal year | CTVA | LMNR |
|---|---|---|
| FY2025 | $17.4B | $153.7M |
| FY2024 | $16.9B | $185.9M |
| FY2023 | $17.2B | $174.4M |
| FY2022 | $17.5B | $179.3M |
| FY2021 | $15.7B | $161.4M |
| FY2020 | $14.2B | $159.9M |
| FY2019 | $13.8B | $166.5M |
| FY2018 | $14.3B | $124.3M |
Net income by year
Bottom line
| Fiscal year | CTVA | LMNR |
|---|---|---|
| FY2025 | $1.1B | $-16.0M |
| FY2024 | $907.0M | $7.7M |
| FY2023 | $735.0M | $9.4M |
| FY2022 | $1.1B | $-236,000 |
| FY2021 | $1.8B | $-3.4M |
| FY2020 | $681.0M | $-16.4M |
| FY2019 | $-959.0M | $-5.9M |
| FY2018 | $-5.1B | $20.2M |
More in this industry